Case Report

Wernicke Encephalopathy Complicating Lymphoma Therapy: Case Report and Literature Review

Authors: Scott Boniol, MD, Molly Boyd, MD, Rachel Koreth, MD, Gary V. Burton, MD

Abstract

Thiamine deficiency can occur in any disease that results in inadequate intake or excessive loss of vitamin B1. In addition to increased thiamine consumption secondary to high cell turnover, cancer patients frequently have reduced oral intake as a direct result of their cancer or from cancer treatments. However, Wernicke encephalopathy (cerebral Beriberi), a clinical manifestation of thiamine deficiency, has rarely been associated with cancer patients. We report a case of Wernicke encephalopathy in a nonalcoholic patient with lymphoma. Although thiamine deficiency rarely potentiates clinical sequelae in cancer patients, it is important to recognize the risk and the clinical signs and manifestations so that prompt therapy can be initiated to reverse morbidity.


Key Points


* Wernicke encephalopathy is a reversible condition caused by thiamine deficiency.


* Thiamine deficiency occurs in any disease state that causes inadequate intake or excessive loss of vitamin B1.


* Wernicke encephalopathy manifests as encephalopathy, oculomotor dysfunction, and gait ataxia.


* Treatment of Wernicke encephalopathy requires intravenous thiamine prior to any glucose-containing solutions so as not to precipitate the disease.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Finglas PM. Thiamine. Int J Vitam Nutr Res 1993;63:270–274.
 
2. Seligmann R, Levi R, Konijn AM, et al. Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad Med J 2001;77:582–585.
 
3. Kalmanchey R, Roos R, Majtenyi K, et al. Wernicke-encephalopathy in children with cancer. Med Pedriatr Oncol 1994;22:133–136.
 
4. Comin-Anduix B, Boren J, Martinez S, et al. The effect of thiamine supplementation on tumour proliferation: a metabolic control analysis study. Eur J Biochem 2001;268:4177–4182.
 
5. Basu TK, Dickerson JW. The thiamine status of early cancer patients with particular reference to those with breast and bronchial carcinomas. Oncology 1976;33:250–252.
 
6. Victor M, Adams RA, Collins GH. The Wernicke-Korsakoff syndrome and related disorders due to alcoholism and malnutrition. Philadelphia, FA Davis, 1989.
 
7. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341–345.
 
8. Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51–60.
 
9. Leigh D, McBurney A, McIlwain H. Erythrocyte transketolase activity in the Wernicke-Korsakoff syndrome. Br J Psychiatry 1981;139:153–156.
 
10. O' Keefe ST. Thiamine deficiency in elderly people. Age Ageing 2000;29:99–101.
 
11. Warach SJ, Charness ME. Imaging the brain lesions of alcoholics. In Greenberg JO (ed). Neuroimaging: A companion to Adams and Victor's principles of neurology. New York, McGraw-Hill 1994;503.
 
12. McDowell JR, Le Blanc HJ. Computed tomographic findings in Wernicke-Korsakoff syndrome. Arch Neurol 1984;41:453–454.
 
13. Mensing JW, Hoogland PH, Slooff JL. Computed tomography in the diagnosis of Wernicke's encephalopathy: a radiological-neuropathological correlation. Ann Neurol 1984;16:363–365.
 
14. Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 1998;171:1131–1137.
 
15. Charness ME. Intracranial voyeurism: revealing the mammillary bodies in alcoholism. Alcohol Clin Exp Res 1999;23:1941–1944.
 
16. Charness ME, DeLaPaz RL. Periodic alternating nystagmus in an alcoholic with small mammillary bodies. Neurology 1988;38(Suppl):421.
 
17. Charness ME, DeLaPaz RL. Mammillary body atrophy in Wernicke's encphalpathy: antemortem identification using magnetic resonance imaging. Ann Neurol 1987;22:595–600.
 
18. Park SH, Kim M, Na DL, et al. Magnetic resonance reflects the pathological evolution of Wernicke encephalopathy. J Neuroimaging 2001;11:406–410.
 
19. Koguchi K, Nakatsuji Y, Abe K, et al. Wernicke's encephalopathy after glucose infusion. Neurology 2004;62:512.
 
20. Langlais PJ, Mair RG. Protective effects of the glutamate antagonis MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 1990;10:1664–1674.
 
21. Martin PR, Singleton CK, Hiller-Sturmhofel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health 2003;27:134–142.
 
22. Thomson AD, Ryle PR, Shaw GK. Ethanol, thiamine, and brain damage. Alcohol Alcohol 1983;18:27.
 
23. Agabio R. Thiamine administration in alcohol-dependent patients. Alcohol Alcohol 2005;40:155–156.
 
24. Thomson AD, Cook CC, Touquet R, et al. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol 2002;37:513–521.
 
25. Day E, Bentham P, Callaghan R, et al. Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004;CD004033.
 
26. Ambrose ML, Bowden SC, Whelan G. Thiamine treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res 2001;25:112–116.